Current Medicinal Chemistry

This journal supports open access

Editor-in-Chief:

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK

Back

Become EABM
Become Reviewer

Volume 26 - Issue 25



Meet Our Editorial Board Member promotion: free to download

Volume: 26   Issue: 25
Pp: 4697-4697
Eng-Ang Ling
DOI: 10.2174/092986732625190930103340



Management of Peripheral Neuropathy Induced by Chemotherapy

Volume: 26   Issue: 25
Pp: 4698-4708
Maayan Fradkin, Ron Batash, Shiran Elmaleh*, Ronen Debi , Pamela Schaffer , Moshe Schaffer and Noam Asna
DOI: 10.2174/0929867326666190107163756



The Role of Adipokines in the Establishment and Progression of Head and Neck Neoplasms

Volume: 26   Issue: 25
Pp: 4726-4748
Theodora Tzanavari, Jason Tasoulas, Chrysoula Vakaki , Chrysovalantou Mihailidou , Gerasimos Tsourouflis and Stamatios Theocharis *
DOI: 10.2174/0929867325666180713154505



Animal Venom Peptides as a Treasure Trove for New Therapeutics Against Neurodegenerative Disorders

Volume: 26   Issue: 25
Pp: 4749-4774
Xinwang Yang*, Ying Wang, Chunyun Wu and Eng-Ang Ling*
DOI: 10.2174/0929867325666181031122438



Therapeutic Approaches for the Management of Sleep Disorders in Geriatric Population

Volume: 26   Issue: 25
Pp: 4775-4785
Mireille Salas-Crisóstomo, Pablo Torterolo , André Barciela Veras, Nuno Barbosa Rocha, Sérgio Machado and Eric Murillo-Rodríguez*
DOI: 10.2174/0929867325666180904113115



Therapeutic Prospects in Preeclampsia - A Mini-Review

Volume: 26   Issue: 25
Pp: 4786-4798
N.S. Das, S.T. Dheen, E.A. Ling, B.H. Bay and D.K. Srinivasan*
DOI: 10.2174/0929867326666190228115423



Flavonoids as P-gp Inhibitors: A Systematic Review of SARs

Volume: 26   Issue: 25
Pp: 4799-4831
Jiahua Cui*, Xiaoyang Liu and Larry M.C. Chow
DOI: 10.2174/0929867325666181001115225



The Promising Role of Plant Tannins as Bioactive Antidiabetic Agents

Volume: 26   Issue: 25
Pp: 4852-4884
Mohammed Ajebli and Mohamed Eddouks*
DOI: 10.2174/0929867325666180605124256



Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies

Volume: 26   Issue: 25
Pp: 4885-4913
Agnieszka Jankowska, Grzegorz Satała, Anna Partyka, Anna Wesołowska*, Andrzej J. Bojarski, Maciej Pawłowski and Grażyna Chłoń-Rzepa*
DOI: 10.2174/0929867326666190710172002